Trump: Tariffs will be imposed on medicines!

According to CCTV News, on April 8th local time, US President Trump announced in a speech that the United States will impose tariffs on pharmaceuticals.
Trump stated that the United States does not produce its own medications and other health-improving products. The prices paid for drugs in the U.S. are often many times higher than those in countries that produce pharmaceuticals. Trump believes that once tariffs are imposed on medications, pharmaceutical companies will establish factories in the U.S. because it is the "largest market."
European pharmaceutical companies warned at a meeting with the President of the European Commission on the 8th local time that US tariffs will accelerate the trend of the industry moving from Europe to the US. EFPIA, a pharmaceutical industry trade lobbying group whose members include European pharmaceutical giants Bayer, Novartis, and Novo Nordisk, said that it has called on the EU President to push for "rapid and fundamental action" to mitigate the risk of an exodus to the US.
【Copyright and Disclaimer】The above information is collected and organized by PlastMatch. The copyright belongs to the original author. This article is reprinted for the purpose of providing more information, and it does not imply that PlastMatch endorses the views expressed in the article or guarantees its accuracy. If there are any errors in the source attribution or if your legitimate rights have been infringed, please contact us, and we will promptly correct or remove the content. If other media, websites, or individuals use the aforementioned content, they must clearly indicate the original source and origin of the work and assume legal responsibility on their own.
Most Popular
-
Layoffs, Divestments, Plant Closures While Pouring Billions: BASF Undergoes Major Transformation!
-
Ascend Adipic Acid Hit By Force Majeure, Market Expects Supply Resumption In Mid-September
-
Raw Material Supply Shortage! INEOS Phenol Declares Force Majeure on Phenol and Acetone Businesses
-
South Korea initiates anti-dumping investigation against Chinese PVC suspension resin! The target is Tianjin Bohua and Wanhua Chemical. How to break through?
-
Sixth national procurement set to be implemented: A “Reshuffling” Moment for the $10-Billion Medical Device Market